tiprankstipranks
Trending News
More News >
LadRx (LADX)
OTHER OTC:LADX
US Market

LadRx (LADX) Price & Analysis

Compare
369 Followers

LADX Stock Chart & Stats

$0.12
$0.00(0.00%)
At close: 4:00 PM EST
$0.12
$0.00(0.00%)

LADX FAQ

What was LadRx’s price range in the past 12 months?
LadRx lowest stock price was $0.00 and its highest was $2.80 in the past 12 months.
    What is LadRx’s market cap?
    LadRx’s market cap is $59.41K.
      When is LadRx’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were LadRx’s earnings last quarter?
      Currently, no data Available
      Is LadRx overvalued?
      According to Wall Street analysts LadRx’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does LadRx pay dividends?
        LadRx does not currently pay dividends.
        What is LadRx’s EPS estimate?
        LadRx’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does LadRx have?
        LadRx has 495,092 shares outstanding.
          What happened to LadRx’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of LadRx?
          Currently, no hedge funds are holding shares in LADX
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            LadRx

            LadRx (LADX) is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Operating within the pharmaceutical and healthcare sectors, the company leverages its proprietary technology platforms to create novel drug candidates aimed at addressing unmet medical needs in oncology.
            Similar Stocks
            Company
            Price & Change
            Follow
            Biodexa Pharmaceuticals
            Q/C Technologies
            Salarius Pharmaceuticals
            Scinai Immunotherapeutics
            Oragenics

            Ownership Overview

            <0.01%100.00%
            Insiders
            <0.01% Other Institutional Investors
            100.00% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks